
Danish Pharma Faces Uncertainty Over U.S. Drug Pricing Order
Published on: May 16, 2025, 11:21 p.m. | Source: Devdiscourse
Denmark's business minister criticized U.S. President Trump's executive order mandating lower drug prices, highlighting the challenges it poses for Danish pharmaceutical firms. The order sets price targets and may lead to tariffs if not met. Industry representatives express concern over increased trade barriers and investment uncertainty.